Histone acetylation regulates the cell-specific and interferon-γ - Inducible expression of extracellular superoxide dismutase in human pulmonary arteries

American Journal of Respiratory Cell and Molecular Biology

Volumn 45, Issue 5, 2011, Pages 953-961

  Zelko, Igor N ^a,b   Stepp, Marcus W ^a   Vorst, Alan L ^a   Folz, Rodney J ^a,b  

^a University of Louisville School of Medicine   (United States)

^b UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

Endothelial cells; Epigenetic; Extracellular superoxide dismutase; Promoter; Pulmonary arteries; Smooth muscle cells; Transcription

Indexed keywords

AZACITIDINE; EXTRACELLULAR SUPEROXIDE DISMUTASE; GAMMA INTERFERON; JANUS KINASE; TRICHOSTATIN A;

ARTICLE; CPG ISLAND; DNA METHYLATION; ENDOTHELIUM CELL; EPIGENETICS; HISTONE ACETYLATION; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ARTERY; MOLECULAR MECHANICS; PROMOTER REGION; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER;

ACETYLATION; CPG ISLANDS; DNA METHYLATION; ENDOTHELIAL CELLS; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASE INHIBITORS; HISTONES; HUMANS; HYDROXAMIC ACIDS; INTERFERON-GAMMA; JANUS KINASES; MUSCLE, SMOOTH, VASCULAR; PROMOTER REGIONS, GENETIC; PULMONARY ARTERY; STAT TRANSCRIPTION FACTORS; SUPEROXIDE DISMUTASE;

EID: 80555143048     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0012OC     Document Type: Article

References (40)

1. Stralin P, Karlsson K, Johansson BO, Marklund SL. The interstitium of the human arterial wall contains very large amounts of extracellular superoxide dismutase. Arterioscler Thromb Vasc Biol 1995;15:2032-2036.
2. Marklund SL. Expression of extracellular superoxide dismutase by human cell lines. Biochem J 1990;266:213-219. (Pubitemid 20069042)
3. Karlsson K, Marklund SL. Binding of human extracellular-superoxide dismutase C to cultured cell lines and to blood cells. Lab Invest 1989;60:659-666. (Pubitemid 19154515)
4. Abrahamsson T, Brandt U, Marklund SL, Sjoqvist PO. Vascular bound recombinant extracellular superoxide dismutase Type C protects against the detrimental effects of superoxide radicals on endothelium-dependent arterial relaxation. Circ Res 1992;70:264-271.
5. Laursen JB, Rajagopalan S, Galis Z, TarpeyM, Freeman BA, Harrison DG. Role of superoxide in angiotensin II - induced but not catecholamine-induced hypertension. Circulation 1997;95:588-593. (Pubitemid 27063033)
6. Hatori N, Sjoquist PO, Marklund SL, Ryden L. Effects of recombinant human extracellular-superoxide dismutase Type C on myocardial infarct size in pigs. Free Radic Biol Med 1992;13:221-230.
7. Kitayama J, Yi C, Faraci FM, Heistad DD. Modulation of dilator responses of cerebral arterioles by extracellular superoxide dismutase. Stroke 2006;37:2802-2806. (Pubitemid 44922543)
8. Welch WJ, Chabrashvili T, Solis G, Chen Y, Gill PS, Aslam S, Wang X, Ji H, Sandberg K, Jose P, et al. Role of extracellular superoxide dismutase in the mouse angiotensin slow pressor response. Hypertension 2006;48:934-941. (Pubitemid 44611008)
9. Brown KA, Chu Y, Lund DD, Heistad DD, Faraci FM. Gene transfer of extracellular superoxide dismutase protects against vascular dysfunction with aging. Am J Physiol Heart Circ Physiol 2006;290:H2600-H2605. (Pubitemid 43846091)
10. Lund DD, Chu Y, Miller JD, Heistad DD. Protective effect of extracellular superoxide dismutase on endothelial function during aging. Am J Physiol Heart Circ Physiol 2009;296:H1920-H1925.
11. Nozik-Grayck E, Suliman HB, Majka S, Albietz J, Van Rheen Z, Roush K, Stenmark KR. Lung EC-SOD overexpression attenuates hypoxic induction of EGR-1 and chronic hypoxic pulmonary vascular remodeling. Am J Physiol Lung Cell Mol Physiol 2008;295:L422-L430.
12. Van Rheen Z, Fattman C, Domarski S, Majka S, Klemm D, Stenmark KR, Nozik-Grayck E. Lung EC-SOD overexpression lessens bleomycin- induced pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol 2011;44:500-508.
13. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA. Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
14. Zelko IN, Folz RJ. Myeloid zinc finger (MZF)-like, Kruppel-like and ETS families of transcription factors determine the cell-specific expression of mouse extracellular superoxide dismutase. Biochem J 2003;369:375-386. (Pubitemid 36174208)
15. Zelko IN, Folz RJ. Sp1 and Sp3 transcription factors mediate trichostatin A-induced and basal expression of extracellular superoxide dismutase. Free Radic Biol Med 2004;37:1256-1271. (Pubitemid 39296750)
16. Zelko IN, Mueller MR, Folz RJ. Transcription factors Sp1 and Sp3 regulate expression of human extracellular superoxide dismutase in lung fibroblasts. Am J Respir Cell Mol Biol 2008;39:243-251.
17. Zelko IN, Mueller MR, Folz RJ. CpG methylation attenuates Sp1 and Sp3 binding to the human extracellular superoxide dismutase promoter and regulates its cell-specific expression. Free Radic Biol Med 2010;48:895-904.
18. Hitchler MJ, Oberley LW, Domann FE. Epigenetic silencing of SOD2 by histone modifications in human breast cancer cells. Free Radic Biol Med 2008;45:1573-1580.
19. Itoh S, Ozumi K, Kim HW, Nakagawa O, McKinney RD, Folz RJ, Zelko IN, Ushio-Fukai M, Fukai T. Novel mechanism for regulation of extracellular SOD transcription and activity by copper: role of antioxidant-1. Free Radic Biol Med 2009;46:95-104.
20. Bogdan C, Schleicher U. Production of interferon-gamma by myeloid cells: fact or fancy? Trends Immunol 2006;27:282-290. (Pubitemid 43850405)
21. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW. Gamma-interferon regulates vascular smooth muscle proliferation and IA antigen expression in vivo and in vitro. Circ Res 1988;63:712-719.
22. Hansson GK, Holm J. Interferon-gamma inhibits arterial stenosis after injury. Circulation 1991;84:1266-1272.
23. Gomez D, Reich NC. Stimulation of primary human endothelial cell proliferation by IFN. J Immunol 2003;170:5373-5381. (Pubitemid 36617822)
24. Wang Y, Bai Y, Qin L, Zhang P, Yi T, Teesdale SA, Zhao L, Pober JS, Tellides G. Interferon-gamma induces human vascular smooth muscle cell proliferation and intimal expansion by phosphatidylinositol 3-kinase dependent mammalian target of rapamycin raptor complex 1 activation. Circ Res 2007;101:560-569. (Pubitemid 351325873)
25. Yokoyama M, Hirata K, Kawashima S, Kawahara Y. Regulation of nitric oxide synthase gene expression by cytokines. J Card Fail 1996;2:S179-S185. (Pubitemid 126686407)
26. Matsubara T, Ziff M. Increased superoxide anion release from human endothelial cells in response to cytokines. J Immunol 1986;137:3295-3298. (Pubitemid 17181704)
27. Pfefferkorn LC, Guyre PM, Fanger MW. Functional comparison of the inductions of NADPH oxidase activity and Fc gamma RI in IFN gamma-treated U937 cells. Mol Immunol 1990;27:263-272. (Pubitemid 20111697)
28. Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002;18:1427-1431. (Pubitemid 35414532)
29. Liu T, Castro S, Brasier AR, Jamaluddin M, Garofalo RP, Casola A. Reactive oxygen species mediate virus-induced STAT activation: role of tyrosine phosphatases. J Biol Chem 2004;279:2461-2469. (Pubitemid 38114229)
30. Bai Y, Ahmad U, Wang Y, Li JH, Choy JC, Kim RW, Kirkiles-Smith N, Maher SE, Karras JG, Bennett CF, et al. Interferon-gamma induces X-linked inhibitor of apoptosis-associated factor-1 and NOXA expression and potentiates human vascular smooth muscle cell apoptosis by STAT3 activation. J Biol Chem 2008;283:6832-6842.
31. Maher F, Harrison LC. Stabilization of glucose transporter mRNA by insulin/IGF-1 and glucose deprivation. Biochem Biophys Res Commun 1990;171:210-215. (Pubitemid 20283192)
32. Tien M, Berlett BS, Levine RL, Chock PB, Stadtman ER. Peroxynitrite-mediated modification of proteins at physiological carbon dioxide concentration: pH dependence of carbonyl formation, tyrosine nitration, and methionine oxidation. Proc Natl Acad Sci USA 1999;96:7809-7814. (Pubitemid 29328363)
33. Szabo C, Ischiropoulos H, Radi R. Peroxynitrite: biochemistry, pathophysiology and development of therapeutics. Nat Rev Drug Discov 2007;6:662-680. (Pubitemid 47207751)
34. Maunakea AK, Nagarajan RP, Bilenky M, Ballinger TJ, D'Souza C, Fouse SD, Johnson BE, Hong C, Nielsen C, Zhao Y, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature 2010;466:253-257.
35. Stralin P, Marklund SL. Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 2000;151:433-441. (Pubitemid 30618760)
36. Brady TC, Chang LY, Day BJ, Crapo JD. Extracellular superoxide dismutase is upregulated with inducible nitric oxide synthase after NF-kappa B activation. Am J Physiol 1997;273:L1002-L1006. (Pubitemid 27508347)
37. Goriely S, Demonte D, Nizet S, De Wit D, Willems F, Goldman M, Van Lint C. Human IL-12(p35) gene activation involves selective remodeling of a single nucleosome within a region of the promoter containing critical Sp1-binding sites. Blood 2003;101:4894-4902. (Pubitemid 36857751)
38. Choi JC, Holtz R, Murphy SP. Histone deacetylases inhibit IFN-gamma inducible gene expression in mouse trophoblast cells. J Immunol 2009;182:6307-6315.
39. Hacker S, Dittrich A, Mohr A, Schweitzer T, Rutkowski S, Krauss J, Debatin KM, Fulda S. Histone deacetylase inhibitors cooperate with IFN-gamma to restore caspase-8 expression and overcome TRAIL resistance in cancers with silencing of caspase-8. Oncogene 2009;28:3097-3110.
40. Li J, Baud O, Vartanian T, Volpe JJ, Rosenberg PA. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc Natl Acad Sci USA 2005;102:9936-9941. (Pubitemid 40993671)